The Latest Headlines at American Banking and Market News
Anil Doradla Sells 3,000 Shares of Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) Stock
Grid Dynamics Holdings, Inc. (NASDAQ:GDYN – Get Free Report) CFO Anil Doradla sold 3,000 shares of Grid Dynamics stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $10.00, for a total transaction... More of this article »
David Buchanan Tennant Acquires 300,000 Shares of Highland Copper Company Inc. (CVE:HI) Stock
Highland Copper Company Inc. (CVE:HI – Get Free Report) Director David Buchanan Tennant purchased 300,000 shares of the business’s stock in a transaction dated Friday, May 3rd. The shares were acquired at an average price... More of this article »
Britt E. Ide Sells 687 Shares of NorthWestern Energy Group, Inc. (NYSE:NWE) Stock
NorthWestern Energy Group, Inc. (NYSE:NWE – Get Free Report) Director Britt E. Ide sold 687 shares of the stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $51.30, for a total... More of this article »
Justin J. Noznesky Sells 1,500 Shares of AtriCure, Inc. (NASDAQ:ATRC) Stock
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) insider Justin J. Noznesky sold 1,500 shares of the business’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $24.09, for a total... More of this article »
John R. Moore Sells 1,956 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) General Counsel John R. Moore sold 1,956 shares of the stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $18.91, for a total... More of this article »
Paul Edward Chamberlain Sells 375 Shares of TriNet Group, Inc. (NYSE:TNET) Stock
TriNet Group, Inc. (NYSE:TNET – Get Free Report) Director Paul Edward Chamberlain sold 375 shares of the stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $101.02, for a total value of $37,882.50.... More of this article »
Choreo LLC Invests $56,000 in United States Natural Gas Fund LP (NYSEARCA:UNG)
Choreo LLC purchased a new stake in United States Natural Gas Fund LP (NYSEARCA:UNG – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased... More of this article »
R Michael Carruthers Sells 2,157 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CFO R Michael Carruthers sold 2,157 shares of Edgewise Therapeutics stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $18.91,... More of this article »
Choreo LLC Invests $201,000 in Hilton Grand Vacations Inc. (NYSE:HGV)
Choreo LLC bought a new position in shares of Hilton Grand Vacations Inc. (NYSE:HGV – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,000 shares... More of this article »
Choreo LLC Sells 483 Shares of Cameco Co. (NYSE:CCJ)
Choreo LLC trimmed its stake in Cameco Co. (NYSE:CCJ – Free Report) (TSE:CCO) by 9.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional... More of this article »
33,812 Shares in Pitney Bowes Inc. (NYSE:PBI) Purchased by Choreo LLC
Choreo LLC purchased a new stake in Pitney Bowes Inc. (NYSE:PBI – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor... More of this article »
Choreo LLC Grows Stock Holdings in Enovix Co. (NASDAQ:ENVX)
Choreo LLC grew its stake in Enovix Co. (NASDAQ:ENVX – Free Report) by 17.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned... More of this article »
Choreo LLC Makes New Investment in G1 Therapeutics, Inc. (NASDAQ:GTHX)
Choreo LLC acquired a new stake in shares of G1 Therapeutics, Inc. (NASDAQ:GTHX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).... More of this article »